Results 121 to 130 of about 23,836 (161)

scFv-based biologics in diabetes: from therapeutic potential to clinical prospects. [PDF]

Front Immunol
Ge S, Wang L, Huang Y, Guo H, Wei F, Li P, Li S, Liu Q, Xu J, Xiao Y, Piress Dias AC, Ji L.   +11 more
europepmc   +1 more source

Discovery of human antibody specific to the spike glycoprotein subunit 2 of SARS-CoV-2 and characterization of its broad-spectrum neutralizing activity. [PDF]

Infect Med (Beijing)
Chi Y, Yin H, Huang C, Ge Y, Liu J, Ding Y, Shi F, Cui Z, Ning S, Jiao Y, Cui L.   +10 more
europepmc   +1 more source

Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells. [PDF]

Cancer Immunol Res
Kuo CF, Tong Z, Kuo YC, Park M, King J, Ly K, Parcutela B, Stern LA, Wang Z, Hibbard JC, Aguilar B, Starr R, Chang WC, Ostberg JR, Rossi D, Clark MC, Alizadeh D, Forman SJ, Williams JC, Brown CE.   +19 more
europepmc   +1 more source

Engineering Antibodies into Targeted Chimeras: From Recognition Modules to Programmable Degraders. [PDF]

Adv Sci (Weinh)
Chen K, Hu Q.
europepmc   +1 more source

Hemoglobin's α-Helix-to-β-Sheet Transition Enables Targeted mRNA Delivery to the Lung. [PDF]

Adv Sci (Weinh)
Liu X, Li S, Wu G, Li S, Huang LS, Li X, Zhao Y, Lu W, Sun C, Cao Q, Fang Y, Cao Y.   +11 more
europepmc   +1 more source

A simple, rapid, resin-free platform for purification of vascular endothelial growth factor using a calcium-responsive fusion protein. [PDF]

Bioresour Bioprocess
Lee J, Park H, Im K, Byun S, Kim S.
europepmc   +1 more source

Efficient PE system PE7-scFv-MLH1dn by optimizing the configuration of La and MLH1dn. [PDF]

Synth Syst Biotechnol
Li X, Qing C, Li B, Zhao D, Li P, Tang W, Bi C, Zhang X.   +7 more
europepmc   +1 more source

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer. [PDF]

Front Immunol
Scholler J, Song A, Deshmukh M, Song D, Gabunia K, Ji M, Liu S, Fan TJ, Gulendran G, June CH, Siegel DL.   +10 more
europepmc   +1 more source

CAR T-cells for the treatment of CNS malignancies. [PDF]

Front Immunol
Kisamore CA, Owolabi PJ, Kisamore CO, Walker WH.   +3 more
europepmc   +1 more source